: U.S. stocks open lower after flurry of rate hikes by global central banks
U.S. stocks opened lower, headed for a fourth straight day of losses, after a flurry of rate hikes by global central banks, including half-point increases...
: NRG Energy stock rallies to lead the S&P 500’s winners after repurchase program boost, activist investor call to oust CEO
Shares of NRG Energy Inc. NRG jumped 2.8% toward a two-month high in morning trading Thursday, enough to pace the S&P 500’s SPX gainers, after...
: SEC levies $4 mln penalty on JPMorgan Chase for deleting 47 mln ‘electronic communications’
The Securities and Exchange Commission on Thursday said it’s requiring JPMorgan Chase & Co. JPM to pay a $4 million penalty for allegedly violating rules...
: Microsoft, Activision hearing over FTC injunction blocking deal begins Thursday
Microsoft Corp. MSFT and Activision Blizzard Inc. ATVI have their day in court Thursday as a federal judge decides whether to uphold the Federal Trade...
: Bank stocks fall again in fourth straight day of losses
Bank stocks are down on Thursday for the fourth straight day amid talk of higher interest rates and increased capital requirements by regulators to strengthen...
Market Extra: Global growth outlook deteriorates on central bank rate hikes, raising risks for U.S. and markets
Henry Nicholls/Agence France-Presse/Getty ImagesA flurry of interest-rate hikes from European central banks on Thursday is darkening the outlook for the global economy, reigniting fears about...
: Kroger raises dividend, to boost implied yield to above 2.5%
Shares of Kroger Co. KR rose 0.2% in midday trading Thursday, after the grocer raised its quarterly dividend by 11.5%, to 29 cents a share...
: Traders see more than 20% chance of Fed rate increase in November as global central banks deliver flurry of hikes
Fed funds futures traders are pricing in a 21.9% chance that the Federal Reserve’s main interest-rate target will get to at least between 5.5%-5.75% by...
: Oncolytics Biotech’s stock soars 25% after pelareorep is selected for inclusion in late-stage pancreatic cancer trial
The stock of Oncolytics Biotech Inc. ONCY soared 25% Thursday, after the San Diego-based company said its pelareorep therapy has been selected for inclusion in...